156 related articles for article (PubMed ID: 37831346)
1. Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy.
Abdel-Tawab MS; Mohamed MG; Doudar NA; Rateb EE; Reyad HR; Elazeem NAA
Mol Biol Rep; 2023 Dec; 50(12):9793-9803. PubMed ID: 37831346
[TBL] [Abstract][Full Text] [Related]
2. Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy.
Akhbari M; Khalili M; Shahrabi-Farahani M; Biglari A; Bandarian F
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414764
[TBL] [Abstract][Full Text] [Related]
3. miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy.
Akpınar K; Aslan D; Fenkçi SM; Caner V
Diagnosis (Berl); 2022 Nov; 9(4):499-507. PubMed ID: 35976169
[TBL] [Abstract][Full Text] [Related]
4. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
[TBL] [Abstract][Full Text] [Related]
6. Metformin mediates MicroRNA-21 regulated circulating matrix metalloproteinase-9 in diabetic nephropathy: an in-silico and clinical study.
Khokhar M; Roy D; Bajpai NK; Bohra GK; Yadav D; Sharma P; Purohit P
Arch Physiol Biochem; 2023 Dec; 129(6):1200-1210. PubMed ID: 34087084
[TBL] [Abstract][Full Text] [Related]
7. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1.
Meng L; Li G; Liu X; Jiang J; Zhu M; Sun Y
Clin Lab; 2018 Jul; 64(7):1177-1182. PubMed ID: 30146830
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
Liu Q; Wang M; Xu T; Liang W; Yang F
J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.
Nasser M; Ibrahim KMF; Elnabawi WM; Ahmed TM
Egypt J Immunol; 2020 Jun; 27(2):81-92. PubMed ID: 33548980
[TBL] [Abstract][Full Text] [Related]
10. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.
Park S; Moon S; Lee K; Park IB; Lee DH; Nam S
Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545
[TBL] [Abstract][Full Text] [Related]
11. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
[TBL] [Abstract][Full Text] [Related]
12. A clinical and in-silico study of microRNA-21 and growth differentiation factor-15 expression in pre-diabetes, type 2 diabetes and diabetic nephropathy.
Agarwal RG; Khokhar M; Purohit P; Modi A; Bajpai NK; Bohra GK; Garg MK; Sharma P
Minerva Endocrinol (Torino); 2023 Jun; 48(2):172-185. PubMed ID: 35103454
[TBL] [Abstract][Full Text] [Related]
13. miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy.
Jia Y; Guan M; Zheng Z; Zhang Q; Tang C; Xu W; Xiao Z; Wang L; Xue Y
J Diabetes Res; 2016; 2016():7932765. PubMed ID: 26942205
[TBL] [Abstract][Full Text] [Related]
14. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker.
Al-Kafaji G; Al-Mahroos G; Al-Muhtaresh HA; Skrypnyk C; Sabry MA; Ramadan AR
Exp Ther Med; 2016 Aug; 12(2):815-822. PubMed ID: 27446281
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of hsa-miR-100-5p May Be a Protective Factor in the Early Stages of Nephropathy in Type 1 Diabetes Mellitus.
Pinheiro AHG; Pereira BO; Silva LSD; Melo FTC; Souza ACCB; Leal VSG; Figueiredo PBB; Neto JFA; Santos MCD; Queiroz NNM; Felício KM; Ribeiro-Dos-Santos Â; Felício JS; Cavalcante GC
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891851
[TBL] [Abstract][Full Text] [Related]
17. Review of early circulating biomolecules associated with diabetes nephropathy - Ideal candidates for early biomarker array test for DN.
Quan KY; Yap CG; Jahan NK; Pillai N
Diabetes Res Clin Pract; 2021 Dec; 182():109122. PubMed ID: 34742785
[TBL] [Abstract][Full Text] [Related]
18. YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines.
Umapathy D; Dornadula S; Krishnamoorthy E; Mariappanadar V; Viswanathan V; Ramkumar KM
Immunobiology; 2018 Nov; 223(11):718-727. PubMed ID: 30077474
[TBL] [Abstract][Full Text] [Related]
19. Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy.
Wang J; Wang G; Liang Y; Zhou X
J Diabetes Res; 2019; 2019():5204394. PubMed ID: 31218232
[TBL] [Abstract][Full Text] [Related]
20. Interplay between long non-coding RNA MALAT1 and pyroptosis in diabetic nephropathy patients.
Shoeib HM; Keshk WA; Al-Ghazaly GM; Wagih AA; El-Dardiry SA
Gene; 2023 Jan; 851():146978. PubMed ID: 36270460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
